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Abstract
Background: Experimental animal studies, in vitro experiments, and clinical assessments have shown that metal
toxicity can impair immune responses. We analyzed data from a United States representative National Health and
Nutrition Examination Survey (NHANES) to explore associations between chronic infections and elevated blood
concentrations of lead and cadmium among non-smoking NHANES participants.
Methods: NHANES data from 1999 to 2012 were examined and weighted to represent the United States population.
Multivariable logistic regression was used to estimate adjusted odds ratios (AOR) and 95 % confidence intervals (CI)
for heavy metal associations with seropositivity for Helicobacter pylori, Toxoplasma gondii, and Hepatitis B virus (HBV)
infections.
Results: Available 2-year survey cycles for infection seroprevalence varied by pathogen, from 1 to 7 cycles. Available
sample size, disease seroprevalence, and participant age range also varied by pathogen of interest. After controlling for
demographic characteristics and general health condition, an elevated blood lead level above the survey population
median was significantly associated with seropositivity for all three pathogens (AORs = 1.2–1.5). In addition, an elevated
blood cadmium level above the median was significantly associated with HBV (AOR = 1.5; 95 % CI = 1.2–2.0) and H.
pylori (AOR = 1.5; 95 % CI = 1.2–1.7) seropositivity. Age-specific analyses for H. pylori and T. gondii indicated stronger
associations among children under 13 years of age, particularly for lead exposure and H. pylori seropositivity, and
weaker associations among those over 35 years of age.
Conclusions: The results of this cross-sectional human health survey suggest that the immunological effects of lead
and cadmium toxicity may be associated with an increased susceptibility to chronic infections.
Keywords: Helicobacter pylori, Toxoplasma, Hepatitis B, Nutrition surveys, Seroprevalence, Heavy metals, Immune
system, Immunomodulation
Background
Human exposure to heavy metals can impair innate and
humoral immune responses and lead to an increased
susceptibility to infections as well as the development of
autoimmune diseases [1, 2]. Immunomodulatory effects
include modifying inflammatory reactions, increasing
cytotoxic responses, and altering the number of circulat-
ing lymphocytes, natural killer (NK) cells, and memory
cells [3–7]. Prenatal exposures to arsenic and cadmium
have been shown to impact genes that may underlie al-
tered infectious disease susceptibility [8]. While direct
immunotoxicity of heavy metals has been examined
through animal studies, in vitro experiments, clinical as-
sessments, and occupationally-exposed cohort studies [7,
9, 10], few large-scale human epidemiological studies
have been performed to assess the adverse immuno-
logical effects of heavy metal exposure. In this analysis,
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we examined associations between three common chronic
infections: Helicobacter pylori, Toxoplasma gondii, and
Hepatitis B virus (HBV) and two ubiquitous heavy metals:
Lead (Pb) and Cadmium (Cd).
Naturally found in the earth’s crust, lead is used to make
batteries, ammunition, pipes, and roofing materials [11].
In the past, it was also added to paint and gasoline.
Humans are exposed to lead by inhaling contaminated air,
dust, or lead dust, as well as ingesting contaminated soil,
water, food, paint chips, and painted toys. Construction
sites [12] and hazardous waste sites [13] present occupa-
tional exposure risks. Absorption of lead in the body de-
pends on several factors, including nutrition status, health,
and age; adults typically absorb up to 10 % of ingested lead
while children can retain up to 50 % [11]. Absorbed lead
accumulates in mineralizing and soft tissues. Unborn chil-
dren are at the greatest risk of adverse health effects asso-
ciated with lead exposure, including low birth weight,
premature birth, and abortion. In young children, lead ex-
posure has been associated with decreased intelligence,
slowed growth, and hearing problems. Lead has not been
shown to be a human carcinogen, but exposure to high
levels of lead can result in kidney and brain damage [11].
Also naturally found in the earth’s crust, cadmium is a
byproduct of smelting and is used in metal plating as well
as in making batteries, pigments, and plastics. Cadmium
is released into soil, water, and air via mining/refining
practices, fertilizer application, fossil fuel combustion, and
waste disposal, where it can accumulate in aquatic organ-
isms and agricultural crops [14]. Humans are primarily ex-
posed to cadmium through smoking tobacco and eating
contaminated vegetables and grains. Occupational expos-
ure risks through inhalation or accidental ingestion are
also of concern. Up to 10 % of ingested cadmium enters
the body through the digestive tract [15]. The body can
convert cadmium to a non-harmful form; however, at high
levels the liver and kidneys can become overloaded. As
one of the most toxic heavy metals [16], acute toxicity in-
duces vomiting and diarrhea. Chronic low-level exposures
can result in kidney damage and brittle bones [17]. The
U.S. Environmental Protection Agency (EPA) has desig-
nated cadmium in the B1 classification as a probable hu-
man carcinogen, citing studies linking lung cancer and
workers who inhaled cadmium [18].
We analyzed data from the nationally representative
National Health and Nutrition Examination Survey
(NHANES) to explore associations between H. pylori,
T. gondii and HBV seropositivity and elevated blood
concentrations of lead and cadmium among non-smoking
NHANES participants.
Methods
Seven 2-year cycles of continuous NHANES data (1999–
2012) [19] were examined. Data were collected using a
complex sampling survey design; therefore, approaches
recommended by the U.S. Centers for Disease Control
and Prevention (CDC) for SAS survey analysis proce-
dures were followed and appropriate sample weights
according to the NHANES Analytic and Reporting
Guidelines were applied [20].
Seroprevalence data
Available serology results for H. pylori (1999–2000), T.
gondii (1999–2004, 2009–10), and HBV (1999–2012)
were examined. For H. pylori, sera from eligible partici-
pants ≥3 years old were tested by the CDC for immuno-
globulin G (IgG) antibodies using an enzyme-linked
immunosorbent assay (ELISA) from Wampole Laboratories
(Cat #446404, Carter Wallace, Inc., Cranbury, NJ). A di-
chotomous seropositivity cut-off was provided by the CDC,
in which an optical density at 450 nm (OD450) ≥1.1 = posi-
tive and OD450 < 1.1 = negative [21]. For T. gondii, available
serum from eligible participants 6–49 years old (1999–
2004) and ≥6 years old (2009–10) were tested by the CDC
for IgG antibodies using enzyme immunoassays (EIAs)
(Bio-rad, Hercules, CA). A dichotomous seropositiv-
ity cut-off was provided by the CDC (1999–2004:
IgG ≥10 IU/mL = positive; IgG <10 IU/mL = negative;
2009–2010: IgG ≥33 IU/mL = positive; IgG <33 IU/
mL = negative).
Only naturally-acquired HBV infections were consid-
ered in this analysis. The commercially-available Ortho
HBc ELISA Test System (Ortho-Clinical Diagnostics,
Raritan, NJ), a qualitative ELISA, was used by the CDC
to detect total antibodies against hepatitis B core (HBc)
antigen. Anti-HBc is present in the serum of HBV-
infected individuals and is considered an accurate sero-
logical marker of acute, chronic, or resolved HBV infec-
tions, but not a marker of vaccine-induced immunity.
Participants who had received at least 1 dose of the 3-
dose HBV vaccine series, as well as those with unknown
vaccine status, were excluded from the analysis. In
addition, participants seronegative for anti-HBc but
seropositive for antibodies against the HBV surface anti-
gen, a marker for both natural and vaccine-induced im-
munity, were also excluded from the analysis. NHANES
participants ≥6 years old were tested for HBV seropreva-
lence from 1999 to 2012. NHANES reported HBV ser-
ology results dichotomously as positive or negative.
Blood lead and cadmium levels
For the 1999–2002 survey years, lead and cadmium were
simultaneously measured in whole blood by atomic ab-
sorption spectrophotometry [22–24] with quantifications
based on the measurement of light absorbed at
228.8 nm and 283.3 nm, respectively, by ground-state
atoms of cadmium and lead from either an electrodeless
discharge lamp (EDL) or by a hollow cathode lamp
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(HCL) source [25]. For the remaining survey years
(2003–2012), whole blood lead and cadmium concentra-
tions were determined by inductively coupled plasma
mass spectrometry (ICP-MS), a multi-element analytical
technique based on quadrupole ICP-MS technology
[26]. The lower detection limits for lead were 0.30 μg/dL
for NHANES 1999–2004 and 0.25 μg/dL for 2005–2012.
For cadmium, the limit of detection (LOD) was 0.30 μg/
dL for NHANES 1999–2002, 0.20 μg/dL for 2003–2010,
and 0.16 μg/dL for 2011–2012. Results below the LOD





Whole blood concentrations of lead and cadmium
were assessed by several exposure measurements, in-
cluding weighted geometric means (GM), levels greater
than the study population median, each 2-fold increase
(doubling) in concentration, as well as by categories to
assess potential nonlinear associations. Quartiles were
used for lead, but for cadmium the distribution was
skewed due to samples below the limit of detection, so
tertiles were used to prevent overlapping values. Metal
exposures were stratified by seroreactivity and associa-
tions between elevated blood concentrations and sero-
positivity were examined. Weighted linear correlations
between log-transformed lead and cadmium concentra-
tions were measured using Pearson’s r.
Data analysis
All analyses were conducted using SAS v9.3 (SAS, Inc.,
Cary, NC, USA). Because cigarette smoking is highly
correlated with toxic heavy metal exposures [27], we re-
stricted our analyses to a domain of non-smokers, de-
fined as having a serum cotinine level <10 ng/mL) [28].
Differences in seroprevalence by participants’ demo-
graphics were evaluated using the Rao-Scott chi-square
test for unadjusted bivariate comparisons. The authors
selected covariates of interest a priori, based on previous
reports and biologic plausibility, to examine associations
with seropositivity, including NHANES cycle, age, gen-
der, race/ethnicity, family income (</≥$20,000), country
of birth origin (born in the United States or elsewhere),
self-reported general health condition (excellent/very
good, good, fair/poor), source of tap water in home (mu-
nicipal or well), crowded housing (total number of indi-
viduals living in a household divided by number of
rooms in the home, excluding bathroom and kitchen),
and ever using a needle to take street/illicit drugs. Be-
cause of its role in the replication of bacteria and viruses
and its potential impact in the uptake of divalent metals
such as lead and cadmium, we also considered serum iron
as a potentially important confounding variable [29].
Associations between elevated lead and cadmium blood
levels and seropositivity for each pathogen were examined
with unadjusted and adjusted logistic regression models to
ascertain Rao-Scott chi-square odds ratio (OR) estimates
and 95 % confidence intervals (CI).
Multivariable logistic regression was used to account
and control for key demographic characteristics and
known risk factors, with one model fitted for each ser-
ology outcome that included lead or cadmium individu-
ally. Covariates with p values <0.2 in a simple logistic
model were considered for inclusion in multivariable
models. Multivariable models were selected using step-
wise backwards elimination of covariates with p values
>0.05, with the highest corresponding p-value removed
at each step while minimizing the Akaike information
criterion (AIC). Collinearity of lead and cadmium levels
was confirmed to be insignificant by evaluating the Pear-
son correlation coefficient, variation inflation factor, and
condition number for each model.
Trend tests were performed by regressing the outcome
of interest on categorical median concentrations in each
percentile (quartiles for lead and tertiles for cadmium)
and including all of the same model covariates. Depart-
ure from additivity for the joint association of elevated
blood lead and cadmium concentrations was assessed by
estimating the relative excess risk due to interaction
(RERI) and 95 % confidence intervals using the delta
method described by Hosmer and Lemeshow [30]. The
products of blood lead and cadmium concentrations
were added to the logistic regression models to evaluate
interaction between the two exposures of interest on a
multiplicative scale.
To examine whether the associations differed by age,
we stratified the analysis by three age groups (under
13 years of age, 13-35 years of age and over 35 years of
age) for H. pylori and T. gondii. Age stratification was
not considered for HBV because too few children (only
2 were under 13 years of age) were seropositive.
Results
Helicobacter pylori
Exposure and H. pylori serology data were available for
5994 non-smoking participants ≥3 years old from a
single NHANES cycle (1999–2000) (Fig. 1a). Overall
seroprevalence for IgG antibodies against H. pylori was
23.1 %. Seroreactivity significantly varied by age, race,
family income level, country of birth origin, general
health condition, and crowded housing (Table 1). The
blood lead GM concentration for all participants was
1.50 (95 % CI = 1.43–1.57), with 0.8 % of results below the
LOD; the GM for blood cadmium was 0.33 (95 % CI =
0.31–0.36), with 35.1 % below the LOD (Table 2). In
examining the association between seropositivity and
blood concentrations of lead and cadmium (Figs. 2 and 3),
the adjusted odds ratios associated with a 2-fold increase
in blood lead and cadmium were 1.22 (95 % CI = 1.12–
1.34) and 1.37 (95 % CI = 1.17–1.62), respectively (Table 3).
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There were significant trends (p < 0.0001) in increasing
seroprevalence by percentiles of lead and cadmium
(Table 3). Lead and cadmium concentrations were only
slightly correlated (Pearson’s r = 0.26), and no evidence
was found to suggest additive or multiplicative interaction
between lead and cadmium exposure in association with
H. pylori seropositivity (Table 4).
Positive associations between metal exposure and H.
pylori seropositivity were stronger among children under
13 years old. Children in the highest quartile of lead ex-
posure had markedly higher rates of H. pylori seroposi-
tivity (Table 5, OR = 21.2, 95 % CI = 8.32–53.8). The
strength of the associations for both lead and cadmium
declined among those aged 13–35 years. Among those
over 35 years old, associations were not statistically
significant (Additional file 1: Tables S1 and S2).
Toxoplasma gondii
For T. gondii, 18,425 non-smoking participants ≥6 years
old had complete data available from 4 NHANES cycles
(1999–2004 and 2009–10) (Fig. 1b). The seroprevalence
for IgG antibodies against T. gondii among the study
population was 11.0 %. Seroreactivity against T. gondii
significantly varied by NHANES cycle, age, race, family
income level, country of birth origin, general health
condition, and crowded housing (Table 1). The blood
lead GM concentration for all participants was 1.13
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Fig. 1 Flow charts illustrating derived study populations for each pathogen of interest: a) Helicobacter Pylori; b)Toxoplasma gondii c) Hepatitis B
Virus. NHANES 1999-2012
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Table 1 Weighted seroprevalence by participant characteristics among nonsmokers, NHANES 1999–2012
Characteristic H. pylori T. gondii Hepatitis B virus
N Positive (%)a Pb N Positive (%)a Pb N Positive (%)a Pb
Total 5994 23.1 18,425 11.0 17,389 4.9
NHANES cycle years
1999–2000 5994 23.1 – 4084 13.5 0.0001 2926 5.0 0.8283
2001–2002 – – 4669 8.0 2955 4.5
2003–2004 – – 4089 9.3 2420 5.7
2005–2006 – – – – 2157 5.3
2007–2008 – – – – 2507 4.3
2009–2010 – – 5583 12.8 2466 5.0
2011–2012 – – – 1958 4.9
Age (years)
≤ 13 1721 7.2 <0.0001 5127 3.5 <0.0001 613 0.4 <0.0001
14–40 2307 20.2 9252 10.5 4788 2.9
≥ 41 1966 33.4 4046 16.2 11,988 5.9
Gender
Male 2785 22.7 0.5279 8529 11.5 0.1633 8171 5.5 0.0185
Female 3209 23.5 9896 10.5 9218 4.5
Race
Non-Hispanic White 1912 14.6 <0.0001 6320 9.0 <0.0001 8365 2.6 <0.0001
Non-Hispanic Black 1300 37.2 4313 11.7 3124 13.4
Mexican American 2586 45.2 6967 17.2 5083 4.3
Other 196 31.2 825 12.4 817 27.4
Family income
≥ $20,000 2991 18.3 <0.0001 10,997 9.6 <0.0001 10,661 4.0 <0.0001
< $20,000 2650 31.5 6725 14.3 6027 7.4
Country of birth origin
United States 4675 17.6 <0.0001c 14,417 7.7 <0.0001 12,919 3.2 <0.0001
Other 1314 53.4 4002 27.3 4459 14.0
General health condition
Excellent/very good 3190 17.2 <0.0001 10,634 8.2 <0.0001 7622 3.8 <0.0001
Good 1855 28.0 5452 13.7 5829 5.6
Fair/poor 943 42.0 2330 20.9 3925 7.5
Source of tap water
Municipal 5306 22.9 0.9746 16,294 10.9 0.9501 13,218 5.4 <0.0001
Public/private well 589 23.0 1768 11.0 1962 2.6
Crowded housingd
≤ 1 person/room 4109 20.9 <0.0001 12,739 10.1 <0.0001 12,872 4.8 0.0091
> 1 person/room 1806 34.2 5490 15.7 2401 6.5
Injected drug user
No/unknown – – – 18,377 8.4 0.5850 17,294 4.8 <0.0001
Yes – – 48 11.0 95 18.5
aWeighted percentages
bRao-Scott chi-square test used
cUnweighted Wald chi-square used
dCalculated as total number of individuals living in a household divided by number of rooms in the home (excluding bathroom and kitchen)
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the LOD; the GM for blood cadmium was 0.25 (95 %
CI = 0.24–0.25), with 44.7 % below the LOD (Table 2).
For the association between T. gondii seropositivity
and metal concentrations (Figs. 2 and 3), the adjusted
odds ratios associated with a doubling of blood lead
and cadmium were 1.19 (95 % CI = 1.12–1.28) and
1.06 (95 % CI = 0.96–1.18), respectively (Table 3).
There was a significant trend (p < 0.0001) in increas-
ing seroprevalence by quartiles of lead (Table 3). The
association between lead and T. gondii seropositivity
was slightly weaker among children under 13 years
old (Table 5, AOR = 1.12; 95 % CI = 0.84–1.49, per
doubling of blood lead) compared to those 13–35
years old (AOR = 1.25; 95 % CI = 1.12–1.40) and those
over 35 years old (AOR = 1.21; 95 % CI = 1.07–1.37)
(Additional file 1, Tables S1 and S2). Lead and cadmium
concentrations were only slightly correlated (Pearson’s r =
0.24), and no evidence was found to suggest additive or
multiplicative interaction between lead and cadmium ex-
posure in association with T. gondii seropositivity (Table 6).
Hepatitis B virus
After excluding HBV-vaccinated participants and those
with unknown vaccine status, exposure and HBV ser-
ology data were available for 17,389 non-smoking partic-
ipants ≥6 years old from 7 NHANES cycles (1999–2012)
(Fig. 1c). Overall seroprevalence for anti-HBc was 4.9 %.
Seroreactivity significantly varied by age, gender, race,
family income level, country of birth origin, general
health condition, source of home tap water, crowded
housing, and using illegal/illicit injectable drugs (Table 1).
The blood lead GM concentration for all participants
was 1.41 (95 % CI = 1.38–1.44), with 0.5 % of results
below the LOD; the GM for blood cadmium was 0.30
(95 % CI = 0.30–0.31), with 26.4 % below the LOD
(Table 2). In examining the association between anti-
HBc seropositivity and blood concentrations (Figs. 2 and
3), the adjusted odds associated with a 2-fold increase
(doubling) in blood levels of lead and cadmium were
1.19 (95 % CI = 1.08–1.32) and 1.38 (95 % CI = 1.23–
1.55) respectively (Table 3). There were significant
trends in increasing seroprevalence by percentiles of lead
(p = 0.0077) and cadmium (p < 0.0001) (Table 3). Lead
and cadmium concentrations were only slightly corre-
lated (Pearson’s r = 0.31), and no evidence was found to
suggest additive or multiplicative interaction between
lead and cadmium exposure in association with HBV
seropositivity (Table 7).
We considered serum iron in all analyses, however, we
excluded it from the final models because it was statisti-
cally insignificant in all models, did not impact the coef-
ficients of lead and cadmium, and reduced the effective
sample size due to missing data.
Discussion
We observed statistically significant increased odds of
elevated blood lead and cadmium levels among non-
smoking NHANES participants seropositive for H. pyl-
ori, T. gondii, and HBV. The associations between lead
and cadmium exposures and H. pylori seropositivity
were strongly pronounced among participants under
13 years of age, particularly for lead. For each of the
three chronic infections, non-smoking participants had
an approximately 20 % increase in odds of being sero-
positive for each doubling of blood lead levels (Table 3).
For HBV and H. pylori infections, a doubling of blood
cadmium levels corresponded to nearly a 40 % increase
in odds of being seropositive (Table 3). We found no
Table 2 Distribution of blood levels for lead and cadmium (in μg/mL) among non-smoking NHANES participants, 1999–2012
Survey years Pathogen N Blood lead Blood cadmium
Weighted Geometric





















5994 1.50 (1.43–1.57) 0.94 1.43 2.18 0.80 0.33 (0.31–0.36) 0.20 0.29 0.40 35.1
Negative 4073 1.41 (1.34–1.47) 0.88 1.34 2.01 0.96 0.31 (0.29–0.34) 0.20 0.26 0.38 39.6





18,425 1.13 (1.10–1.16) 0.72 1.10 1.69 0.95 0.25 (0.24–0.25) 0.15 0.20 0.38 44.7
Negative 16,449 1.09 (1.07–1.12) 0.70 1.09 1.60 1.01 0.24 (0.24–0.25) 0.15 0.19 0.34 46.4
Positive 1976 1.44 (1.40–1.49) 1.00 1.40 2.10 0.47 0.29 (0.28–0.31) 0.17 0.29 0.40 30.4
1999–2012 Hepatitis B
virus
17,389 1.41 (1.38–1.44) 0.90 1.40 2.10 0.51 0.30 (0.30–0.31) 0.20 0.30 0.44 26.4
Negative 16,231 1.39 (1.36–1.42) 0.90 1.39 2.09 0.53 0.30 (0.29–0.30) 0.19 0.29 0.42 14.7
Positive 1158 1.80 (1.72–1.88) 1.23 1.77 2.61 0.18 0.41 (0.38–0.43) 0.27 0.40 0.59 27.1
LOD limit of detection
aLOD = 0.30 (1999–2004), 0.25 (2005–2012)
bLOD = 0.30 (1999–2002). 0.20 (2003–2010), 0.16 (2011–2012)
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evidence of additive or multiplicative interaction be-
tween lead and cadmium. These results support the
growing evidence that heavy metal exposure has dele-
terious effects on the immune response.
Suppression of the immune response may lead to in-
creased susceptibility of the host to chronic infection. In
addition to an immunotoxic effect, heavy metals may
also influence the severity of infection. An in vitro study
found that cadmium-induced oxidative stress increased
influenza virus replication in Madin-Darby canine kid-
ney (MDCK) cells [31]. An experimental study in mice
suggested that during a Coxsackievirus B3 infection,
a
b
Fig. 2 Box plots of 10th, 25th, 50th, 75th, and 90th percentiles for blood levels of lead (panel a) and cadmium (panel b) by pathogen seropositivity
among non-smoking NHANES participants, 1999–2012
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levels of mercury flux between tissues such that higher
levels were retained in infected organs [32]. Another
mouse study reported that pretreatment with a single
dose of cadmium or manganese increased the severity of
symptoms and mortality to sub-lethal viral infections, in-
cluding Venezuelan Equine Encephalitis virus [33].
Our analysis contributes to the growing body of litera-
ture that has used NHANES data to examine associa-
tions between heavy metal exposures and infections.
Previous NHANES analyses have reported associations
between chronic HBV infections and blood mercury
levels in women of child-bearing age [34], higher blood
cadmium levels among HIV-infected individuals [35], el-
evated blood lead levels and an increased risk of herpes
simplex virus type 2 infections [36], as well as an inverse
association between urinary arsenic and Varicella Zoster
virus seroprevalence [37].
HBV is a bloodborne virus that attacks the liver. HBV
pathogenesis results from interactions between the virus
and the host’s immune system. Immunosuppression of
the host can result in chronic HBV infections. Lead and
cadmium are hepatotoxic [38, 39] and have been shown
a
b
Fig. 3 Geometric means and 95 % confidence intervals of blood metal of lead (panel a) and cadmium (panel b) by pathogen seropositivity
among non-smoking NHANES participants, 1999–2012
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to increase viral activity [31, 40]. In addition, dietary
cadmium has been shown to enhance the progres-
sion of hepatocellular tumors in HBV-infected mice
[41]. A recent study in China found decreased HBV
surface antibody (HBsAb) levels among preschool
children exposed to lead from electronic and electrical
waste (e-waste) [42]. The authors reported almost 50 % of
children with chronic lead exposure failed to develop suffi-
cient immunity against HBV in response to vaccination;
therefore, their immune systems may be more susceptible
to HBV infection in the future. Another study conducted in
Babylon found blood levels of lead to be significantly higher
in HBV patients compared to healthy controls [43].
T. gondii, an obligate intracellular protozoan, is one of
the most widespread zoonotic parasites in the world
[44]. When oocysts are ingested by an intermediate host
such as humans, they migrate in the host’s body and
form permanent cysts in various organs and tissues [45].
Toxoplasmosis is lifelong infection that has the potential
to reactivate and cause severe disease and even death in
immunocompromised individuals. Existing data on the
effect of lead and cadmium on chronic toxoplasmosis
are lacking; however, lead has been suggested to inhibit
intracellular killing of Leishmania parasites [46]. Al-
though age-specific associations between blood lead and
T. gondii seropositivity were relatively similar, among
Table 3 Seropositivity associated with blood lead and cadmium levels, for each two-fold increase and across percentiles, among
non-smoking NHANES participants, 1999–2012. All subjects
Heavy metal H. pylori T. gondii Hepatitis B virus
Positive
(Weighted %)
AOR (95 % CI)a,b Positive
(Weighted %)
AOR (95 % CI)a,c Positive
(Weighted %)
AOR (95 % CI)a,d
Per doubling of blood lead 23.1 1.22 (1.12–1.34)e 11.0 1.19 (1.12–1.28) 4.9 1.19 (1.08–1.32)
Blood lead concentration (μg/dL)
Quartile 1 12.7 Ref 5.6 Ref 2.2 Ref
Quartile 2 19.9 1.31 (0.98–1.75) 8.7 1.20 (0.93–1.54) 4.0 1.41 (1.04–1.93)
Quartile 3 24.3 1.39 (1.13–1.72) 12.8 1.53 (1.22–1.91) 6.1 1.79 (1.31–2.43)
Quartile 4 34.1 1.69 (1.33–2.15) 16.5 1.56 (1.28–1.90) 7.1 1.70 (1.23–2.35)
p for trend <0.0001 <0.0001 0.0077
Per doubling of blood cadmium 23.1 1.37 (1.17–1.62) 11.0 1.06 (0.96–1.18) 4.9 1.38 (1.23–1.55)
Blood cadmium concentration (μg/L)
Tertile 1 13.4 Ref 6.9 Ref 2.8 Ref
Tertile 2 22.1 1.51 (1.16–1.97) 9.7 1.34 (1.03–1.74) 3.8 1.09 (0.84–1.43)
Tertile 3 30.5 1.48 (1.25–1.76) 14.4 1.32 (1.03–1.69) 7.7 1.72 (1.32–2.25)
p for trend <0.0001 0.1438 <0.0001
aMultivariable logistic regression used with survey procedures
bAdjusted for age, gender, race/ethnicity, country of birth origin, family income, self-reported general health condition, tap water source, and household crowding
cAdjusted for NHANES cycle, age, gender, race/ethnicity, country of birth origin, family income, self-reported general health condition, and household crowding
dAdjusted for age, gender, race/ethnicity, country of birth origin, family income, self-reported general health condition, and use of illicit/street injected drugs
eBolded font denotes statistically significant (α < 0.05)
Table 4 Effect of interaction between blood lead and blood cadmium levels on odds of H. pylori seropositivity, NHANES 1999–2000
Blood lead levels Blood cadmium levels
<Median ≥Median AOR (95 % CI)
within Pb strataN (Weighted %) AOR (95 % CI) N (Weighted %) AOR (95 % CI)
<Median 1662 (11.6) 1.0 1074 (23.7) 1.38 (1.03–1.97) 1.20 (0.88–1.64)
P = 0.0337 P = 0.2597
≥Median 1436 (22.1) 1.43 (1.10–1.87) 4073 (35.2) 1.63 (1.27–2.10) 1.27 (1.02–1.57)
P = 0.0082 P = 0.0002 P = 0.0313
AOR (95 % CI) within Cd strata 1.32 (0.97–1.79) 1.27 (0.98–1.65)
P = 0.0795 P = 0.0689
Measure of interaction on additive scale: RERI (95 % CI) = -0.21 (−0.74–0.32)
Measure of interaction on multiplicative scale: ratio of ORs (95 % CI) = 0.82 (0.56–1.21); P = 0.3183
AORs are adjusted for age, gender, race/ethnicity, country of birth origin, family income, self-reported general health condition, tap water source, and
household crowding
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children under 13 years old, the association was slightly
weaker compared to older age groups. One of the most
common routes of transmission for T. gondii to humans
in the United States is suspected to be raw meat con-
sumption [45]; therefore, in addition to having more op-
portunities to be infected as one ages, eating habits in
adulthood may also contribute to this observed associ-
ation with older age.
Half of the world's population is infected with H.
pylori [47]. The bacterium colonizes the inner mucus
layer of the stomach epithelium, but the majority of
infections remain asymptomatic. Up to 20 % of H. pylori
infections lead to severe chronic disease outcomes, in-
cluding chronic gastritis, peptic ulcer, gastric mucosa-
associated lymphoid tissue (MALT) lymphoma, and gas-
tric cancer [48–51]. While there are no published data
describing the association between lead and cadmium
and chronic helicobacteriosis, researchers have suggested
that maintaining metal homeostasis, including cadmium
levels, is critical for H. pylori to adapt to and survive in
the gastric environment [52].
The stronger association between H. pylori seroposi-
tivity and lead and cadmium exposures among children
may be due to an increased vulnerability or susceptibil-
ity, due to increased and faster absorption of these
metals during a time when hygienic factors may also
make them more likely to be exposed to H. pylori. Al-
though we controlled for numerous available factors
Table 5 Seropositivity associated with blood lead and cadmium levels, for each two-fold increase and across percentiles, among
non-smoking NHANES participants, 1999–2012. Children under 13 years of agea
Heavy metal H. pylori T. gondii
Positive (Weighted %) AOR (95 % CI)b,c Positive (Weighted %) AOR (95 % CI)b,d
Per doubling of blood lead 7.3 2.61 (1.85–3.67)e 3.5 1.12 (0.84–1.49)
Blood lead concentration (μg/dL)
Quartile 1 0.8 Ref 1.8 Ref
Quartile 2 4.5 5.26 (1.92–14.4) 3.0 1.46 (0.57–3.73)
Quartile 3 5.8 4.75 (1.61–14.0) 3.0 1.17 (0.46–2.95)
Quartile 4 15.5 21.2 (8.32–53.8) 5.7 1.82 (0.75–4.43)
p for trend <0.0001 0.1825
Per doubling of blood cadmium 7.3 2.02 (1.29–3.15) 3.5 1.10 (0.74–1.63)
Blood cadmium concentration (μg/L)
Tertile 1 5.5 Ref 2.1 Ref
Tertile 2 9.9 2.75 (1.30–5.83) 4.1 1.46 (0.63–3.36)
Tertile 3 10.5 2.39 (1.35–4.20) 4.2 1.11 (0.48–2.56)
p for trend 0.0005 0.8214
aOnly two children under 13 were positive for Hepatitis B so it was not considered
bMultivariable logistic regression used with survey procedures
cAdjusted for age, gender, race/ethnicity, country of birth origin, family income, self-reported general health condition, tap water source, and household crowding
dAdjusted for NHANES cycle, age, gender, race/ethnicity, country of birth origin, family income, self-reported general health condition, and household crowding
eBolded font denotes statistically significant (α < 0.05)
Table 6 Effect of interaction between blood lead and blood cadmium levels on odds of T. gondii seropositivity, NHANES 1999–2004,
2009–10
Blood lead levels Blood cadmium levels
<Median ≥Median AOR (95 % CI)
within Pb strataN (Weighted %) AOR (95 % CI) N (Weighted %) AOR (95 % CI)
<Median 4629 (5.2) 1.0 3892 (9.3) 1.24 (0.978–1.59) 1.26 (0.94–1.69
P = 0.0805 P = 0.1222
≥Median 4101 (10.4) 1.45 (1.17–1.79) 5803 (17.0) 1.64 (1.30–2.07) 1.34 (0.97–1.85)
P = 0.0007 P = <0.0001 P = 0.0779
AOR (95 % CI) within Cd strata 1.13 (0.78–1.62) 1.41 (1.22–1.63)
P = 0.5244 P = <0.0001
Measure of interaction on additive scale: RERI (95 % CI) = -0.05 (−0.42–0.32)
Measure of interaction on multiplicative scale: ratio of ORs (95 % CI) = 0.91 (0.69–1.21) P = 0.5262
AORs are adjusted for NHANES cycle, age, gender, race/ethnicity, country of birth origin, family income, self-reported general health condition, and
household crowding
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related to socioeconomic status and living conditions
(income, crowding), these associations could also reflect
a shared environmental susceptibility that we were un-
able to fully control for in our analysis.
We found no evidence to suggest either additive or
multiplicative interaction between elevated lead and cad-
mium levels and their association with seropositivity.
Lead and cadmium share common environmental ex-
posure routes through contaminated food, water, and
soil. Individual toxic metals can interact with toxic and
essential metals in various tissues [53]. Mixed-metal ex-
posure may yield synergistic interactions, or even novel
effects not seen in single metal exposures [54, 55]; how-
ever, information on the interaction of low-dose toxic
metal mixtures is lacking [5, 56]. Studies have reported
that exposure to lead increased the renal response to
low levels of cadmium [57], and a dose-dependent inter-
action between prenatal co-exposure to lead and cad-
mium has been observed [58]. Because lead and
cadmium have common, as well as distinctive, binding
sites and mechanisms of action, the pathophysiological
effects caused by each metal alone may be exacerbated
during co-exposure [59]. It remains unclear whether our
lack of evidence for interaction was because synergistic
interaction does not influence immunomodulatory ef-
fects or because our method of examining co-exposure
was inadequate. Furthermore, including both lead and
cadmium levels as covariates in a single multivariable
model (rather than separately in individual models as re-
ported here), did not significantly change the observed
effects (data not shown).
Continuous NHANES collects valuable health in-
formation from a national, representative sample of
the United States population, making it an effective
tool for hypothesis generation and exploring bio-
marker data for chemical risk assessments [60].
Nonetheless, we recognize the inherent limitations of
its cross-sectional design that prevent us from infer-
ring causality. In addition, combining datasets across
multiple survey years can be a limitation, depending
on the covariates of interest. Questions and medical
exams are not continuous across the survey years. In
addition, several questionnaires and metal exposure
assessments are administered to only subgroups (e.g.
adults ≥20 years old, females of child-bearing age, or
a special one-third subsample of adults). Our goal
was to maintain the largest cohort as possible for
consistency and increased power. Despite these limi-
tations, this study provides risk factor data that can
inform future environmental assessments and pro-
spective human studies to better link cause and ef-
fect for heavy metal exposure and risk of chronic
infections.
Conclusions
Environmental exposure to lead and cadmium, even at
chronic low-level doses, remains a significant public
health concern [54]. The results of this cross-sectional
human health survey suggest that the immunological
effects of lead and cadmium toxicity may result in an
increased susceptibility to chronic infections. While the
mechanisms of immunotoxicity vary by metal type, expos-
ure dose, temporality to infection, severity of infection,
and genetic factors [1, 54, 61, 62], increased environmen-
tal contamination with heavy metals will likely contribute
to an increased incidence of chronic infections in human
populations.
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